NDC 35208-032

Levetiracetam Extended-release

Levetiracetam

Levetiracetam Extended-release is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Intellipharmaceutics Corp.. The primary component is Levetiracetam.

Product ID35208-032_b0da0932-ad12-458d-b4de-5d1174cff448
NDC35208-032
Product TypeHuman Prescription Drug
Proprietary NameLevetiracetam Extended-release
Generic NameLevetiracetam
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2016-10-03
Marketing CategoryANDA / ANDA
Application NumberANDA204511
Labeler NameIntelliPharmaCeutics Corp.
Substance NameLEVETIRACETAM
Active Ingredient Strength750 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 35208-032-10

1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (35208-032-10)
Marketing Start Date2016-10-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 35208-032-10 [35208003210]

Levetiracetam Extended-release TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA204511
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-10-03

NDC 35208-032-60 [35208003260]

Levetiracetam Extended-release TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA204511
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-10-03

Drug Details

Active Ingredients

IngredientStrength
LEVETIRACETAM750 mg/1

OpenFDA Data

SPL SET ID:02727941-c5ea-4f85-beb4-2a00eec73dd0
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 807832
  • 846378
    • UPC Code
  • 0300000000001

    • Pharmacological Class

    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    NDC Crossover Matching brand name "Levetiracetam Extended-release" or generic name "Levetiracetam"

    NDCBrand NameGeneric Name
    10370-195levetiracetam extended-releaselevetiracetam extended-release
    10370-214levetiracetam extended-releaselevetiracetam extended-release
    35208-031Levetiracetam Extended-releaseLevetiracetam Extended-release
    35208-032Levetiracetam Extended-releaseLevetiracetam Extended-release
    40051-079LEVETIRACETAM Extended-releaseLEVETIRACETAM Extended-release
    40051-332LEVETIRACETAM Extended-releaseLEVETIRACETAM Extended-release
    52817-111levetiracetam extended-releaselevetiracetam extended-release
    52817-110levetiracetam extended-releaselevetiracetam extended-release
    60429-349Levetiracetam Extended-ReleaseLevetiracetam Extended-Release
    60429-350Levetiracetam Extended-ReleaseLevetiracetam Extended-Release
    50228-190Levetiracetam Extended-ReleaseLevetiracetam Extended-Release
    50228-189Levetiracetam Extended-ReleaseLevetiracetam Extended-Release
    55488-0519LEVETIRACETAM Extended-releaseLEVETIRACETAM Extended-release
    0054-0224LevetiracetamLevetiracetam
    0121-0799LevetiracetamLEVETIRACETAM
    0121-1598LevetiracetamLEVETIRACETAM
    0121-2397LevetiracetamLEVETIRACETAM
    0121-4799LevetiracetamLEVETIRACETAM
    0121-4802LEVETIRACETAMLEVETIRACETAM
    0143-9574LevetiracetamLevetiracetam
    0143-9673LevetiracetamLevetiracetam
    0228-2167LevetiracetamLevetiracetam
    0378-5613Levetiracetamlevetiracetam
    0378-5615Levetiracetamlevetiracetam
    0378-5617Levetiracetamlevetiracetam
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.